|Bid||2.6200 x 3100|
|Ask||2.6400 x 1200|
|Day's Range||2.5100 - 2.6700|
|52 Week Range||2.3000 - 12.0300|
|Beta (5Y Monthly)||-0.21|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The economy has been tumultuous, but technical analysis helps us see through the static and zero in on the best penny stock opportunities.
BOSTON, July 19, 2020 -- Block & Leviton LLP (www.blockesq.com), a national securities litigation firm, reminds investors that it is investigating the following companies.
LOS ANGELES, CA / ACCESSWIRE / July 13, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BELLUS Health Inc. ("BELLUS" or "the Company") (NASDAQ:BLU) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. BELLUS announced the topline results of its Phase 2 RELIEF trial for BLU-5937 on July 6, 2020.